nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—DRD4—Gilles de la Tourette syndrome	0.264	0.342	CbGaD
Olanzapine—DRD3—Gilles de la Tourette syndrome	0.228	0.295	CbGaD
Olanzapine—DRD2—Gilles de la Tourette syndrome	0.157	0.204	CbGaD
Olanzapine—HTR2A—Gilles de la Tourette syndrome	0.122	0.158	CbGaD
Olanzapine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00328	0.0483	CbGeAlD
Olanzapine—HTR5A—nervous system—Gilles de la Tourette syndrome	0.00266	0.0392	CbGeAlD
Olanzapine—HTR5A—central nervous system—Gilles de la Tourette syndrome	0.00256	0.0378	CbGeAlD
Olanzapine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00204	0.0301	CbGeAlD
Olanzapine—HTR5A—brain—Gilles de la Tourette syndrome	0.00203	0.03	CbGeAlD
Olanzapine—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00114	0.0167	CbGeAlD
Olanzapine—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00109	0.0161	CbGeAlD
Olanzapine—DRD4—brain—Gilles de la Tourette syndrome	0.00101	0.0148	CbGeAlD
Olanzapine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.000996	0.0147	CbGeAlD
Olanzapine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.000959	0.0141	CbGeAlD
Olanzapine—DRD3—nervous system—Gilles de la Tourette syndrome	0.000926	0.0137	CbGeAlD
Olanzapine—FMO3—nervous system—Gilles de la Tourette syndrome	0.000916	0.0135	CbGeAlD
Olanzapine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.000892	0.0131	CbGeAlD
Olanzapine—HTR6—nervous system—Gilles de la Tourette syndrome	0.000891	0.0131	CbGeAlD
Olanzapine—FMO3—central nervous system—Gilles de la Tourette syndrome	0.000882	0.013	CbGeAlD
Olanzapine—HTR1E—brain—Gilles de la Tourette syndrome	0.000868	0.0128	CbGeAlD
Olanzapine—DRD5—nervous system—Gilles de la Tourette syndrome	0.000868	0.0128	CbGeAlD
Olanzapine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.000858	0.0127	CbGeAlD
Olanzapine—DRD5—central nervous system—Gilles de la Tourette syndrome	0.000836	0.0123	CbGeAlD
Olanzapine—H1F0—midbrain—Gilles de la Tourette syndrome	0.000817	0.012	CbGeAlD
Olanzapine—HRH2—nervous system—Gilles de la Tourette syndrome	0.000815	0.012	CbGeAlD
Olanzapine—DRD1—midbrain—Gilles de la Tourette syndrome	0.000807	0.0119	CbGeAlD
Olanzapine—HRH2—central nervous system—Gilles de la Tourette syndrome	0.000785	0.0116	CbGeAlD
Olanzapine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.000779	0.0115	CbGeAlD
Olanzapine—CHRM4—brain—Gilles de la Tourette syndrome	0.000761	0.0112	CbGeAlD
Olanzapine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.00075	0.0111	CbGeAlD
Olanzapine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000711	0.0105	CbGeAlD
Olanzapine—DRD3—brain—Gilles de la Tourette syndrome	0.000708	0.0104	CbGeAlD
Olanzapine—FMO3—brain—Gilles de la Tourette syndrome	0.0007	0.0103	CbGeAlD
Olanzapine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000685	0.0101	CbGeAlD
Olanzapine—HTR6—brain—Gilles de la Tourette syndrome	0.000681	0.01	CbGeAlD
Olanzapine—H1F0—nervous system—Gilles de la Tourette syndrome	0.000672	0.0099	CbGeAlD
Olanzapine—DRD5—brain—Gilles de la Tourette syndrome	0.000663	0.00978	CbGeAlD
Olanzapine—DRD1—nervous system—Gilles de la Tourette syndrome	0.000663	0.00978	CbGeAlD
Olanzapine—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000654	0.00963	CbGeAlD
Olanzapine—H1F0—central nervous system—Gilles de la Tourette syndrome	0.000647	0.00953	CbGeAlD
Olanzapine—HTR3A—nervous system—Gilles de la Tourette syndrome	0.00064	0.00944	CbGeAlD
Olanzapine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000638	0.00941	CbGeAlD
Olanzapine—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000633	0.00933	CbGeAlD
Olanzapine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000627	0.00924	CbGeAlD
Olanzapine—HRH2—brain—Gilles de la Tourette syndrome	0.000623	0.00918	CbGeAlD
Olanzapine—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000617	0.00909	CbGeAlD
Olanzapine—CHRM5—brain—Gilles de la Tourette syndrome	0.000595	0.00877	CbGeAlD
Olanzapine—Amoxapine—DRD4—Gilles de la Tourette syndrome	0.000586	0.0928	CrCbGaD
Olanzapine—ORM1—nervous system—Gilles de la Tourette syndrome	0.000573	0.00845	CbGeAlD
Olanzapine—ORM1—central nervous system—Gilles de la Tourette syndrome	0.000552	0.00813	CbGeAlD
Olanzapine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000544	0.00802	CbGeAlD
Olanzapine—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000537	0.00792	CbGeAlD
Olanzapine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000534	0.00788	CbGeAlD
Olanzapine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000527	0.00778	CbGeAlD
Olanzapine—HTR1D—nervous system—Gilles de la Tourette syndrome	0.00052	0.00767	CbGeAlD
Olanzapine—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000517	0.00763	CbGeAlD
Olanzapine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000515	0.00759	CbGeAlD
Olanzapine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000515	0.00759	CbGeAlD
Olanzapine—H1F0—brain—Gilles de la Tourette syndrome	0.000513	0.00757	CbGeAlD
Olanzapine—DRD1—brain—Gilles de la Tourette syndrome	0.000507	0.00747	CbGeAlD
Olanzapine—Amoxapine—DRD3—Gilles de la Tourette syndrome	0.000506	0.0801	CrCbGaD
Olanzapine—HTR7—midbrain—Gilles de la Tourette syndrome	0.000504	0.00743	CbGeAlD
Olanzapine—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000501	0.00738	CbGeAlD
Olanzapine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000496	0.00731	CbGeAlD
Olanzapine—HTR3A—brain—Gilles de la Tourette syndrome	0.00049	0.00722	CbGeAlD
Olanzapine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000486	0.00717	CbGeAlD
Olanzapine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000484	0.00713	CbGeAlD
Olanzapine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000477	0.00703	CbGeAlD
Olanzapine—Amoxapine—SLC6A3—Gilles de la Tourette syndrome	0.00047	0.0745	CrCbGaD
Olanzapine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000468	0.0069	CbGeAlD
Olanzapine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000466	0.00687	CbGeAlD
Olanzapine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000463	0.00683	CbGeAlD
Olanzapine—Loxapine—DRD4—Gilles de la Tourette syndrome	0.000458	0.0725	CrCbGaD
Olanzapine—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.000447	0.0708	CrCbGaD
Olanzapine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000435	0.00642	CbGeAlD
Olanzapine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000434	0.00639	CbGeAlD
Olanzapine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000419	0.00618	CbGeAlD
Olanzapine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000417	0.00615	CbGeAlD
Olanzapine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000414	0.00611	CbGeAlD
Olanzapine—HTR1B—brain—Gilles de la Tourette syndrome	0.000411	0.00605	CbGeAlD
Olanzapine—CHRM2—brain—Gilles de la Tourette syndrome	0.000409	0.00602	CbGeAlD
Olanzapine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.0004	0.00589	CbGeAlD
Olanzapine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000399	0.00588	CbGeAlD
Olanzapine—HTR1D—brain—Gilles de la Tourette syndrome	0.000398	0.00586	CbGeAlD
Olanzapine—Loxapine—DRD3—Gilles de la Tourette syndrome	0.000395	0.0625	CrCbGaD
Olanzapine—HTR2C—brain—Gilles de la Tourette syndrome	0.000394	0.0058	CbGeAlD
Olanzapine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000392	0.00578	CbGeAlD
Olanzapine—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.000385	0.061	CrCbGaD
Olanzapine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000385	0.00567	CbGeAlD
Olanzapine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000384	0.0609	CrCbGaD
Olanzapine—ALB—brain—Gilles de la Tourette syndrome	0.000384	0.00566	CbGeAlD
Olanzapine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000381	0.00561	CbGeAlD
Olanzapine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000377	0.00556	CbGeAlD
Olanzapine—CHRM1—brain—Gilles de la Tourette syndrome	0.000372	0.00548	CbGeAlD
Olanzapine—HTR2B—brain—Gilles de la Tourette syndrome	0.00037	0.00545	CbGeAlD
Olanzapine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.00037	0.00545	CbGeAlD
Olanzapine—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.000367	0.0582	CrCbGaD
Olanzapine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000367	0.00541	CbGeAlD
Olanzapine—Amoxapine—DRD2—Gilles de la Tourette syndrome	0.00035	0.0554	CrCbGaD
Olanzapine—CHRM3—brain—Gilles de la Tourette syndrome	0.000333	0.00491	CbGeAlD
Olanzapine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000332	0.0525	CrCbGaD
Olanzapine—HTR1A—brain—Gilles de la Tourette syndrome	0.000331	0.00489	CbGeAlD
Olanzapine—HTR7—brain—Gilles de la Tourette syndrome	0.000317	0.00467	CbGeAlD
Olanzapine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000314	0.00463	CbGeAlD
Olanzapine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000309	0.00456	CbGeAlD
Olanzapine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000306	0.0045	CbGeAlD
Olanzapine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000304	0.00448	CbGeAlD
Olanzapine—DRD2—brain—Gilles de la Tourette syndrome	0.000299	0.00441	CbGeAlD
Olanzapine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000298	0.00439	CbGeAlD
Olanzapine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000293	0.00431	CbGeAlD
Olanzapine—ADRA2C—brain—Gilles de la Tourette syndrome	0.000291	0.00429	CbGeAlD
Olanzapine—Loxapine—DRD2—Gilles de la Tourette syndrome	0.000273	0.0433	CrCbGaD
Olanzapine—Amoxapine—HTR2A—Gilles de la Tourette syndrome	0.00027	0.0428	CrCbGaD
Olanzapine—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.000267	0.0422	CrCbGaD
Olanzapine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000258	0.00381	CbGeAlD
Olanzapine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000249	0.00367	CbGeAlD
Olanzapine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000239	0.00353	CbGeAlD
Olanzapine—HRH1—brain—Gilles de la Tourette syndrome	0.000236	0.00349	CbGeAlD
Olanzapine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000235	0.00347	CbGeAlD
Olanzapine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000232	0.00342	CbGeAlD
Olanzapine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00023	0.0034	CbGeAlD
Olanzapine—Clozapine—DRD2—Gilles de la Tourette syndrome	0.000229	0.0363	CrCbGaD
Olanzapine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000227	0.00334	CbGeAlD
Olanzapine—Loxapine—HTR2A—Gilles de la Tourette syndrome	0.000211	0.0334	CrCbGaD
Olanzapine—Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.000206	0.0326	CrCbGaD
Olanzapine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000206	0.00304	CbGeAlD
Olanzapine—HTR2A—brain—Gilles de la Tourette syndrome	0.000198	0.00291	CbGeAlD
Olanzapine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00018	0.00265	CbGeAlD
Olanzapine—Clozapine—HTR2A—Gilles de la Tourette syndrome	0.000177	0.0281	CrCbGaD
Olanzapine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000169	0.0025	CbGeAlD
Olanzapine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000163	0.0024	CbGeAlD
Olanzapine—ABCB1—brain—Gilles de la Tourette syndrome	0.000129	0.00191	CbGeAlD
Olanzapine—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.51e-05	0.000162	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.51e-05	0.000162	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.5e-05	0.000161	CbGpPWpGaD
Olanzapine—ALB—Metabolism—HDC—Gilles de la Tourette syndrome	2.49e-05	0.000161	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.49e-05	0.000161	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.48e-05	0.00016	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.46e-05	0.000158	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000158	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.44e-05	0.000157	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.43e-05	0.000157	CbGpPWpGaD
Olanzapine—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.000155	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.4e-05	0.000155	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.39e-05	0.000154	CbGpPWpGaD
Olanzapine—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.38e-05	0.000154	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000154	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.37e-05	0.000153	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.37e-05	0.000153	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.36e-05	0.000152	CbGpPWpGaD
Olanzapine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.00015	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.3e-05	0.000148	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.29e-05	0.000148	CbGpPWpGaD
Olanzapine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000148	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.29e-05	0.000147	CbGpPWpGaD
Olanzapine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000147	CbGpPWpGaD
Olanzapine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.27e-05	0.000147	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.27e-05	0.000147	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.26e-05	0.000146	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.25e-05	0.000145	CbGpPWpGaD
Olanzapine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000145	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000145	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.24e-05	0.000144	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	2.24e-05	0.000144	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.23e-05	0.000144	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.23e-05	0.000144	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.22e-05	0.000143	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.22e-05	0.000143	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.000143	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.19e-05	0.000141	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	2.18e-05	0.000141	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.17e-05	0.00014	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.16e-05	0.000139	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.16e-05	0.000139	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.15e-05	0.000139	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.14e-05	0.000138	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.14e-05	0.000138	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.13e-05	0.000137	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.09e-05	0.000135	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.09e-05	0.000135	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.08e-05	0.000134	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.08e-05	0.000134	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.08e-05	0.000134	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.07e-05	0.000134	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.06e-05	0.000133	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.05e-05	0.000132	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.05e-05	0.000132	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.04e-05	0.000132	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	2.04e-05	0.000132	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.04e-05	0.000132	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.03e-05	0.000131	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.03e-05	0.000131	CbGpPWpGaD
Olanzapine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.000131	CbGpPWpGaD
Olanzapine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.000131	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.02e-05	0.00013	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.02e-05	0.00013	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.02e-05	0.00013	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.01e-05	0.00013	CbGpPWpGaD
Olanzapine—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.01e-05	0.00013	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.01e-05	0.00013	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.01e-05	0.00013	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2e-05	0.000129	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.99e-05	0.000128	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.99e-05	0.000128	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.98e-05	0.000128	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.98e-05	0.000127	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.97e-05	0.000127	CbGpPWpGaD
Olanzapine—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000127	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.95e-05	0.000126	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.94e-05	0.000125	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.94e-05	0.000125	CbGpPWpGaD
Olanzapine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.94e-05	0.000125	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.93e-05	0.000125	CbGpPWpGaD
Olanzapine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.91e-05	0.000123	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.89e-05	0.000122	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.88e-05	0.000121	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.00012	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.00012	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.85e-05	0.00012	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000119	CbGpPWpGaD
Olanzapine—ALB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	1.85e-05	0.000119	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000119	CbGpPWpGaD
Olanzapine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.85e-05	0.000119	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.85e-05	0.000119	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000119	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000119	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.84e-05	0.000119	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000119	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000119	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.83e-05	0.000118	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.83e-05	0.000118	CbGpPWpGaD
Olanzapine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000118	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000118	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000118	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.82e-05	0.000118	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.82e-05	0.000117	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.82e-05	0.000117	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.81e-05	0.000117	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.81e-05	0.000117	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.8e-05	0.000116	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.8e-05	0.000116	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.79e-05	0.000116	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.79e-05	0.000115	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000115	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.77e-05	0.000114	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.77e-05	0.000114	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.76e-05	0.000113	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000112	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	1.74e-05	0.000112	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000112	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000111	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.72e-05	0.000111	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.71e-05	0.000111	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.7e-05	0.00011	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.69e-05	0.000109	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000109	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.68e-05	0.000108	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000108	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.67e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.67e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.67e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.67e-05	0.000107	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.66e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000107	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.65e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.65e-05	0.000106	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.64e-05	0.000106	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.64e-05	0.000106	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.64e-05	0.000106	CbGpPWpGaD
Olanzapine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	1.62e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.62e-05	0.000104	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.62e-05	0.000104	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.59e-05	0.000103	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000102	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.57e-05	0.000101	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.57e-05	0.000101	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.000101	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.0001	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.55e-05	0.0001	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.55e-05	0.0001	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.55e-05	0.0001	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.54e-05	9.93e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.53e-05	9.86e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.52e-05	9.81e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.51e-05	9.72e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.5e-05	9.71e-05	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.5e-05	9.67e-05	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.49e-05	9.62e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.48e-05	9.57e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.48e-05	9.53e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.46e-05	9.44e-05	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.45e-05	9.36e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.43e-05	9.25e-05	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.43e-05	9.21e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.42e-05	9.14e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.42e-05	9.14e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.41e-05	9.12e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.41e-05	9.1e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.41e-05	9.08e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.4e-05	9.04e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.36e-05	8.78e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.35e-05	8.74e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.35e-05	8.68e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.34e-05	8.62e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.32e-05	8.5e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.32e-05	8.5e-05	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.32e-05	8.49e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.32e-05	8.49e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.3e-05	8.36e-05	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.29e-05	8.34e-05	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.29e-05	8.31e-05	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.28e-05	8.28e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.28e-05	8.24e-05	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.27e-05	8.2e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.27e-05	8.19e-05	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.27e-05	8.18e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.26e-05	8.15e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.23e-05	7.95e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.23e-05	7.93e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.23e-05	7.91e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.21e-05	7.8e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.2e-05	7.71e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.19e-05	7.7e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.19e-05	7.67e-05	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.18e-05	7.6e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.17e-05	7.57e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.17e-05	7.57e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.17e-05	7.55e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.17e-05	7.52e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.16e-05	7.45e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.15e-05	7.43e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.15e-05	7.41e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.14e-05	7.37e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.12e-05	7.19e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.11e-05	7.17e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.1e-05	7.08e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.09e-05	7.06e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.09e-05	7.06e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.09e-05	7.04e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.09e-05	7.02e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.09e-05	7.01e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.09e-05	7e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.08e-05	6.98e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.08e-05	6.96e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.08e-05	6.95e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.07e-05	6.93e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.07e-05	6.9e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.07e-05	6.87e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.06e-05	6.86e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.06e-05	6.83e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.06e-05	6.81e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.06e-05	6.81e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.05e-05	6.75e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.04e-05	6.73e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.04e-05	6.7e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.03e-05	6.61e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.98e-06	6.44e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.92e-06	6.4e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.92e-06	6.4e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.9e-06	6.39e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.87e-06	6.37e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.84e-06	6.35e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.82e-06	6.33e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.74e-06	6.28e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.72e-06	6.27e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.69e-06	6.25e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.36e-06	6.03e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.23e-06	5.95e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.03e-06	5.82e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.33e-06	5.37e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.05e-06	5.19e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8e-06	5.16e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.78e-06	5.02e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.66e-06	4.94e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.06e-06	4.56e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.94e-06	4.47e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.91e-06	4.46e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.89e-06	4.44e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.82e-06	4.4e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.81e-06	4.39e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.32e-06	4.08e-05	CbGpPWpGaD
